Veracyte, Inc. Stock 12‑Month Price Target Raised to $55.8, Implies 1% Downside

• According to estimates from 10 analysts, Veracyte, Inc. stock's average price target has risen from $54.8 to $55.8, with forecasts ranging from $42 to $70 per share
• Based on the Jul. 8 closing price, the updated target implies approximately 1% potential downside
• Consensus rating remains at “Buy” across 11 covering analysts, with 9 Buys, 1 Holds and 1 Sells

Explore more price target data and ratings for Veracyte, Inc. on the , and track all previous and future analyst recommendations for Veracyte, Inc. in the dedicated .

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.